In addition to the open market purchases by Mr. Kaplan it is noteworthy that he has served the company as CEO & director since October 2010, primarily working due to 5,150,000 stock options granted on Sept. 10, 2010 -- 3 million which are exercisable. He has not exercised any of these options per the DEF 14A filed Apr. 22, 2015. In the same filing it was reported that Mr. Kaplan's salary was $ 50,000 and 44,231 for 2013 and 2014 respectively.
In the insidercow report you reference I see Dr. William Destler, president of RIT, purchased 166,667 shares on Oct. 12, 2010.
Also in the report there are various small sales reported by the Gleasmans during 2004 and 2005. Perhaps it should be noted that both Keith and James Gleasman provided services to the company in both years without compensation as reported in the 10KSB reports filed on Apr. 11, 2005 and Apr. 19, 2006. Also reported, Vernon Gleasman provided services without compensation in 2004. Cash to pay one's personal expenses has to come from somewhere.
Though not a director or officer it is noteworthy that Mr. Golisano et al have provided the company with $ 11,500,000 in gross proceeds before deal costs, the last time in March 2014, by buying the Series C and C-2 offerings.
And as mentioned in my last post, per the C-3 offering memorandum dated Dec. 8, 2015, directors and officers intend to subscribe for approximately 2,200,000 C-3 shares.
